Sporothrix schenckii and associated species are agents of human and animal sporotrichosis that cause large sapronoses and zoonoses worldwide. Epidemiological surveillance has highlighted an overwhelming occurrence of the highly pathogenic fungus Sporothrix brasiliensis during feline outbreaks, leading to massive transmissions to humans. Early diagnosis of feline sporotrichosis by demonstrating the presence of a surrogate marker of infection can have a key role for selecting appropriate disease control measures and minimizing zoonotic transmission to humans. We explored the presence and diversity of serum antibodies (IgG) specific against Sporothrix antigens in cats with sporotrichosis and evaluated the utility of these antibodies for serodiagnosis. Antigen profiling included protein extracts from the closest known relatives S. brasiliensis and S. schenckii. Enzyme-linked immunosorbent assays and immunoblotting enabled us to characterize the major antigens of feline sporotrichosis from sera from cats with sporotrichosis (n = 49), healthy cats (n = 19), and cats with other diseases (n = 20). Enzyme-linked immunosorbent assay-based quantitation of anti-Sporothrix IgG exhibited high sensitivity and specificity in cats with sporotrichosis (area under the curve, 1. 0; 95% confidence interval, 0. 94–1; P<0. 0001) versus controls. The two sets of Sporothrix antigens were remarkably cross-reactive, supporting the hypothesis that antigenic epitopes may be conserved among closely related agents. One-dimensional immunoblotting indicated that 3-carboxymuconate cyclase (a 60-kDa protein in S. brasiliensis and a 70-kDa protein in S. schenckii) is the immunodominant antigen in feline sporotrichosis. Two-dimensional immunoblotting revealed six IgG-reactive isoforms of gp60 in the S. brasiliensis proteome, similar to the humoral response found in human sporotrichosis. A convergent IgG-response in various hosts (mice, cats, and humans) has important implications for our understanding of the coevolution of Sporothrix and its warm-blooded hosts. We propose that 3-carboxymuconate cyclase has potential for the serological diagnosis of sporotrichosis and as target for the development of an effective multi-species vaccine against sporotrichosis in animals and humans.
Sporothrix schenckii was originally described in 1898 as the causal agent of a subcutaneous disease in humans in the Mid-Atlantic USA [1]. Subsequently, the disease was reported in rats naturally infected in southeastern Brazil [2] and later in a wide range of animals including dogs, cats, horses, cows, camels, dolphins, goats, mules, birds, pigs, and armadillos. Several Sporothrix spp. , previously reported to be closely related to S. schenckii, are known to establish infections in various hosts, with dissimilar virulence traits [3,4] and responsiveness to antifungal treatment [5]. The S. schenckii complex consists of at least four closely-related species [6,7], ranging from geographically restricted agents such as S. brasiliensis [8,9] to cosmopolitan pathogens such as S. schenckii s. str. and S. globosa [7,10,11]. Sporothrix spp. are endowed with an extraordinary ecological diversity [12–15]; they are frequently recovered from soil, plants debris, and insects (Coleoptera: Scolytidae). Phylogenetic data support a recent habitat shift within Sporothrix from plants to cats [9] that culminated in the largest epizootic transmission in southeastern Brazil [16–19]. Feline sporotrichosis emerged in the 1990s, with S. brasiliensis recovered from many outbreaks [8,20]. More recently, S. brasiliensis has been recognized as a threat to humans [21–23] due to the massive zoonotic transmission in southeastern Brazil that affects thousands of patients regardless of whether they are immunocompetent or immunocompromised [9,24–26]. Cats have been a source of Sporothrix spp. infection transmitted to humans and other animals [18,19,27]. Most human cases occurred in housewives and professionals who had contact with infected animals and a history of scratches or bites [21,28]. The largest epidemic of sporotrichosis due to zoonotic transmission was reported in the State of Rio de Janeiro, Brazil [18,19,21,23,28]; since then, the incidence of sporotrichosis among animals, particularly cats, has increased [8,28,29]. More than 4,000 humans and 4,124 cats were diagnosed at Instituto Nacional de Infectologia (INI) Evandro Chagas /Fundação Oswaldo Cruz by 2012 [30]. Pereira et al. [29] observed that the majority of cats with sporotrichosis in Rio de Janeiro between 2005 and 2011 were male, mongrel, and unneutered, had a median age of 24 months, and presented with three or more cutaneous lesions in non-adjacent locations. This mycosis in cats is hard to treat and generally requires a long period of daily care; these animals do not always respond well to antifungal treatment [30]. Sporothrix is widely distributed in nature, and traumatic inoculation of plant organic matter is classically associated with infection [31]. Feline habits render cats more susceptible to the fungal agent because they are constantly in contact with soil, plant debris, and other cats that may be infected. In cats, a broad spectrum of clinical presentation ranges from single lesions to fatal systemic forms. After monitoring the feline epidemic for 4 years, Schubach et al. [18] observed that the lymphocutaneous form occurred less frequently than did involvement of the mucous membranes of the respiratory tract and upper digestive tract and multiple cutaneous lesions. Some animals present involvement of skin and various internal organs [32]. Cats are susceptible to a variety of fungal infections, including blastomycosis [33], histoplasmosis [34], cryptococcosis [35], candidiasis [36], dermatophytosis [37], aspergillosis [38], coccidioidomycosis [39], and sporotrichosis. Misdiagnosis results in ineffective treatment, which further worsens outcome. Major contributors toward misdiagnosis include the small number of affordable and effective treatment techniques as well as other social issues. Definitive diagnosis of feline sporotrichosis is based on mycological culture, micromorphological characterization, and mold-to-yeast conversion. Histopathological methods and cytopathological examination are useful tools for the presumptive diagnosis of Sporothrix infection in cats [40]. Detection of specific anti-Sporothrix antibodies offers a rapid alternative for accurate diagnosis [41–43]. We recently proposed a serological approach that employs an enzyme-linked immunosorbent assay (ELISA) to diagnose feline sporotrichosis [44] using purified antigen (the S. schenckii ConA binding fraction) and crude antigen, with high sensitivity and specificity. There is a lack of information about feline sporotrichosis and the antigenic components involved in infection; therefore, the present study aimed to explore the diversity of molecules expressed by closely related species (S. brasiliensis and S. schenckii) and that are recognized by immunoglobulin G (IgG) in sera from cats naturally infected with S. brasiliensis. We found remarkable cross-reactivity among S. brasiliensis and S. schenckii antigens, and we identified an immunodominant molecule that is an important biomarker in feline sporotrichosis, irrespective of clinical manifestation. Here, we show that, although S. brasiliensis and S. schenckii may infect different warm-blooded hosts, infection result in highly similar IgG-mediated response in cats compared to humans, what is important for serodiagnosis and to the development of prophylactic or therapeutic vaccine against the enormous health burden of sporotrichosis in endemic areas. This knowledge may enable selection of potential biomarkers that can be used in seroepidemiological studies, diagnosis, and vaccine development, and may contribute to understanding of the pathogenesis of this infection in cats and humans.
This study was performed in strict accordance with recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Ethics in Research Committee of the Fundação Oswaldo Cruz, Rio de Janeiro, Brazil, under license number L-041/06. This study was also approved by the Institutional Ethics in Research Committee of the Federal University of São Paulo under protocol number 0244/11. S. brasiliensis and S. schenckii s. str. from cats and humans were used for protein extraction (Table 1). The dimorphic nature of Sporothrix spp. was demonstrated by converting the fungus to its yeast form at 36°C in brain-heart infusion medium (Difco) and observing typical oval multibudding yeast cells. Molecular identification was performed and confirmed via DNA sequencing of the gene encoding calmodulin [25]. Isolates were selected because they had been previously characterized at the molecular level [3,9, 45,46]; crude exoantigen (CBS 132974 = Ss118; S. schenckii s. str.) was successfully used to diagnose feline sporotrichosis via ELISA [44]. Sporothrix spp. was grown on Sabouraud medium (Difco) agar slants at room temperature (20–25°C) for 7 days. Approximately 2x106 conidia (≥85% viable cells) were used to inoculate 500-mL flasks containing 150 mL of brain-heart infusion broth. Cultures were incubated at 36°C in a rotary shaker (Multitron II, Infors HT) with constant orbital agitation at 110 rpm for 7 days. Whole extracts of Sporothrix yeast cells were obtained as described elsewhere [47]. Briefly, yeast cells (4 mL of each culture) were collected via centrifugation at 5000 x g for 10 min at 4°C and washed three times in ultrapure water. Pellets were frozen in liquid nitrogen and disrupted by gridding. Cells were macerated with a pestle until a fine powder was obtained. This cellular powder was vortexed for 30 min at 4°C in Tris-Ca2+ buffer (20 mM Tris-HCl pH 8. 8,2 mM CaCl2) containing a commercial cocktail of protease inhibitors (1: 1000; GE Healthcare), RNAse and DNAse (1: 1000; GE Healthcare), and 600-μm glass beads (1: 1; Sigma). Cell debris and glass beads were removed via centrifugation at 5000 x g for 10 min, and dithiothreitol (final concentration 20 mM) was added to the supernatant [48]. Protein concentrations were determined using the Bradford method [49]. Cell extracts were kept at -80°C until use. Sera from cats with definitive diagnoses of sporotrichosis (via S. brasiliensis isolation in culture; n = 49) were obtained from INI/Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. The distribution and number of skin lesions of the cats were classified as L1 (cutaneous lesion in only one place), L2 (cutaneous lesion in two non-adjacent places), or L3 (cutaneous lesions in three or more non-adjacent places). During examination, blood was collected via vein puncture and stored in an incubator for 1 h; serum was obtained via centrifugation and stored at -20°C until use. Sera from 19 cats with no evidence of sporotrichosis or other diseases (the control group) were obtained from São Paulo as described elsewhere [44]. Sera from 20 cats with other diseases were also studied to verify cross-reactions with feline infectious peritonitis/coronavirus (5 sera), feline leukemia virus (3 sera), feline immunodeficiency virus (2 sera), leptospirosis (3 sera), rickettsiosis (2 sera), erlichiosis (3 sera), and leishmaniasis (2 sera) as previously described [44] (S1 Diagram). All sera were stored at -20°C until use. Sera from cats with confirmed sporotrichosis and from cats from the control group were tested via ELISA. To determine the best protein concentration for microplate sensitization, whole cellular proteins from S. brasiliensis (CBS 132990 and CBS 132021) and S. schenckii s. str. (CBS 132974 and CBS 132984) were tested and examined by checkerboard titration for antibody detection. Afterward, all microplates were sensitized with concentrations of 3. 6μg/mL (100μL per well in 0. 1 M carbonate-bicarbonate buffer, pH 9. 6). High binding microtiter plates (Corning Costar, Corning) were sensitized for 2 h at 37°C and overnight at 4°C in a refrigerator. The remaining binding sites were blocked with phosphate-buffered saline containing 0. 1% Tween 20 (PBST) and 5% non-fat dry milk (200 μL/well) for 4 h at 37°C. After washing three times with PBST, diluted serum (1: 800 in PBST, 100μL/well) was added in duplicate for 1 h at 37°C. Afterward, 100μL horseradish peroxidase-conjugated goat anti-feline IgG (1: 1000; Southern Biotech) were added to each well and incubated for 1 h at 37°C. After three washes with PBST, 100μL substrate solution (5 mg of o-phenylenediamine in 25 mL of 0. 1 M citrate-phosphate buffer pH 5. 0 plus 10 μL 30% H2O2) were added to each well, and the reaction was interrupted after 8 min in the dark by adding 50 μL 4 N H2SO4. Optical density was read at 492 nm with a Tecan Sunrise 96-well Microplate Reader (Tecan). S. brasiliensis and S. schenckii protein extracts (2 μg) were analyzed via SDS-PAGE with 10% gels [50] and silver-stained [51]. The relative molecular weights of the fractions were estimated using standard broad-range molecular weight markers (Protein Benchmark, Invitrogen). For immunoblotting, proteins (10 μg) from strains CBS 132990, CBS 132021, CBS 132974, and CBS 132984 were resolved with SDS-PAGE and transferred onto 0. 45-μm polyvinylidenedifluoride membranes (Bio-Rad) at 20 V for 30 min with transfer buffer (25 mM Tris base, 192 mM glycine, 20% methanol, pH 8. 3) [52] using a Trans-Blot SD semi-dry device (Bio-Rad). Electrotransference was confirmed by staining with 0. 15% Ponceau S and 1% acetic acid [vol/vol]. Membranes were destained and free binding sites were blocked overnight in phosphate-buffered saline blocking buffer (1% bovine serum albumin supplemented with 0. 05% [vol/vol] Tween 20,5% [wt/vol] skim milk, pH 7. 6) at 4°C. To determine the best dilution of serum, one sample was tested at four dilutions (1: 100,1: 200,1: 500, and 1: 1000) against yeast extracts. Afterward, for all sera, membranes were probed individually with primary antibody diluted 1: 500 at 25°C for 2 h. Membranes were washed three times with Tris-buffered saline (pH 7. 5) containing 0. 05% [vol/vol] Tween-20 for 10 min and incubated with horseradish peroxidase-conjugated goat anti-feline IgG (1: 1000) for 2 h at room temperature. Membranes were then washed with Tris-buffered saline (pH 7. 5) containing 0. 05% [vol/vol] Tween-20 and signal was detected with an enhanced chemiluminescence detection kit (GE Healthcare). Blots were imaged in a transilluminator (Uvitec Cambridge). Allience 4. 7 software was used to take several images at different time exposures, from 2 s each to a total of 10 images over 2 s. Proteins were separated via 2D gel electrophoresis as previously described [45,47]. Briefly, proteins (300 μg) were precipitated using the 2D Clean-up Kit (GE Healthcare) and resuspended in rehydration buffer (7 M urea, 2 M thiourea, 2% CHAPS, 1. 2% DeStreak, 2% vol/vol isoelectric focusing buffer pH 4–7, and trace amounts of bromophenol blue) to a final volume of 250 μL. Immobilized pH gradient strips (pH 4–7,13 cm; GE Healthcare) were rehydrated at 30 V for 12 h. Isoelectric focusing was performed at 20°C using a Multiphor III system (GE Healthcare) as follows: 200 V for 2 h, 500 V for 2 h, 1000 V for 5 h, and a gradient applied from 1000 to 5000 V for 2 h. Finally, the voltage was set to 5000 V for 60,000 Vhr. After 1D isoelectric focusing, the IPG strips were reduced for 15 min with 1. 5% dithiothreitol and alkylated for 15 min with 2. 5% iodocetamide in equilibration buffer (6 M urea, 50 mM Tris-HCl pH 6. 8,30% glycerol, and 2% sodium dodecyl sulfate). Second-dimension separation was carried out by placing equilibrated IPG strips onto 10 % polyacrylamide gels, sealing them with 0. 5 % [wt/vol] low-melting-point agarose, and separating the proteins at 10°C using a Hoefer SE 600 unit (15 mA/gel for 30 min and then 23 mA/gel until the dye front reached the bottom of the gel). Proteins were developed with silver staining [51] or were directly transferred for immunoblotting. For 2D immunoblotting, proteins were transferred onto 0. 45-μm polyvinylidenedifluoride membranes at 25 V for 1 h with transfer buffer [52] using the Trans-Blot SD semi-dry system. The success of electrotransference was evaluated by staining with 0. 15% Ponceau S and 1% acetic acid 1% [vol/vol]. Membranes were destained and free binding sites were blocked overnight in phosphate-buffered saline blocking buffer (1% bovine serum albumin supplemented with 0. 05% [vol/vol] Tween 20,5% [wt/vol] skim milk, pH 7. 6) at 4°C. Membranes obtained from 2D gels were probed with 1: 500 primary antibody (gold standard pooled feline sera; n = 10) under the conditions used for 1D immunoblotting. Immunoreactive antigens were detected using an enhanced chemiluminescence detection kit (GE Healthcare). 2D immunoblots were imaged using the method used for 1D immunoblots. Diagnostic values included sensitivity, specificity, positive predictive value, and negative predictive value. Receiver operating characteristic (ROC) curves were prepared and analyzed to determine the sensitivity and specificity of each antigen preparation for ELISA. The area under the curve (AUC) for ROC analysis was calculated to evaluate the diagnostic value of ELISA. We assumed that a test lacked diagnostic power when the ROC curve was linear with an AUC of 0. 5 (the ROC curve coincided with the diagonal). A powerful test was assumed to yield an AUC of ~1. 0, indicating the absence of both false-positives and false-negatives (the ROC curve reached the upper left corner of the plot). To measure the degree of concordance of the results from preparations from strains CBS 132990, CBS 132021, CBS 132974, and CBS 132984, we calculated the kappa statistic and its 95% confidence interval (CI). Kappa values were interpreted as follows: 0. 00–0. 20, poor agreement; 0. 21–0. 40, fair agreement; 0. 41–0. 60, moderate agreement; 0. 61–0. 80, good agreement; 0. 81–1. 00, very good agreement [53]. P-values ≤0. 05 were considered statistically significant. All calculations were performed with MedCalc Statistical Software version 14. 8. 1 (MedCalc Software bvba; http: //www. medcalc. org). Findings are reported in line with the STARD checklist for studies of diagnostic accuracy (S1 Checklist).
We previously reported a high prevalence of S. brasiliensis in feline sporotrichosis outbreaks [8,9, 20]. Based on this information, the main goal of the present investigation was to evaluate the presence and diversity of serum-derived antibodies against S. brasiliensis antigens in naturally infected cats. Further, we previously proposed the existence of a convergent humoral response in human sporotrichosis against antigens from S. brasiliensis, S. schenckii, and S. globosa [45]. To establish whether S. brasiliensis and S. schenckii express different antigens, we assessed whole cellular protein extracts from two strains of S. brasiliensis plus two strains of S. schenckii s. str. that were previously characterized by molecular [8,9, 25,54] and serological [3,44–47] methods. Remarkably, and in support of our hypothesis that immunological distance increases with phylogenetic distance, sera from these cats reacted similarly, with no significant differences in titer between ELISA plates coated with proteins from S. brasiliensis or S. schenckii (Fig 1). ELISA detection of the four antigen preparations exhibited similar results, medians, and ranges for cats infected with sporotrichosis (n = 49): S. brasiliensis CBS 132990, median 1. 313 OD, 95% CI 1. 262–1. 489 OD; S. brasiliensis CBS 132021, median 1. 632 OD, 95% CI 1. 462–1. 714 OD; S. schenckii CBS 132974, median 1. 296 OD, 95% CI 1. 157–1. 442 OD; and S. schenckii CBS 132984, median 1. 028 OD, 95% CI 1. 027–1. 294 OD (S1 Table). When using the assay to diagnosis cats with sporotrichosis, the area under the ROC curve was 1. 0 (95% CI 0. 94–1. 000; P<0. 0001; Fig 2), indicating excellent performance. The control group of 19 non-Sporothrix infected animals was associated with lower medians and smaller ranges: S. brasiliensis CBS 132990, median 0. 2640 OD, 95% CI 0. 2592–0. 3098 OD; S. brasiliensis CBS 132021, median 0. 2590 OD, 95% CI 0. 2517–0. 2942 OD; S. schenckii CBS 132974, median 0. 2730 OD, 95% CI 0. 2512–0. 3136 OD; and S. schenckii CBS 132984, median 0. 2670 OD, 95% CI 0. 2567–0. 2907 OD (S1 Table). Differences between the absorbance values for the infected and non-infected groups were statistically significant (P<0. 0001). Sera from cats with other infections were non-reactive. Similar cutoff values yielded 100% specificity and sensitivity: S. brasiliensis CBS 132990,0. 377 OD; S. brasiliensis CBS 132021,0. 363 OD; S. schenckii CBS 132974,0. 407 OD; and S. schenckii CBS 132984,0. 346 OD (S1 Fig). ELISA results showed very good agreement for the antigens assayed (kappa = 1. 0). To diagnosis feline sporotrichosis via ELISA, we recommend the use of antigen preparations of S. brasiliensis, since this is the most prevalent species in feline sporotrichosis outbreaks. Antigen diversity was assayed with 1D immunoblots using the four antigen preparations of S. brasiliensis and S. schenckii tested via ELISA. Proteins extracts were evaluated according to the amount of protein extracted, the diversity of bands, the integrity of the samples, and the reproducibility of extraction. Approximately 2 μg of Sporothrix yeast whole-cell extracts were resolved by SDS-PAGE; silver staining revealed numerous proteins ranging from 10 kDa to 160 kDa in size, with different intensities. The Tris-Ca2+ extraction protocol [45,47] was suitable for the study of Sporothrix antigenic molecules during feline sporotrichosis, yielding samples with high amounts of protein and no degradation. As expected, antibodies from cats with sporotrichosis reacted with a wide variety of S. brasiliensis and S. schenckii proteins 20kDa to >160kDa in size (Fig 3). Cat-to-cat variation resulted in characteristic banding patterns for each animal (Fig 3); supporting the hypothesis that in a genetically diverse population, the antibody repertoire is expected to vary among individual cats. On the other hand, we detected minor or no differences in IgG-reacting banding patterns between antigen preparations (Fig 3), consistent with the close genetic distance between S. brasiliensis and S. schenckii [8,9]. Despite this variation, all cats produced antibodies against a 60-kDa molecule in the S. brasiliensis proteome and a 70-kDa molecule in the S. schenckii proteome. The major antigenic S. brasiliensis molecules (CBS 132990 and CBS 132021) recognized by feline IgG consisted of the following sizes: 60 kDa (100% and 100%, respectively), 90 kDa (92% and 92%, respectively), 100 kDa (86% and 86%, respectively), 38 kDa (60% and 56%, respectively), 40 kDa (56% and 58%, respectively), 45 kDa (44% and 42%, respectively), 30 kDa (36% and 26%, respectively), 52 kDa (30% and 32%, respectively), and 110 kDa (28% and 30%, respectively) (Fig 4A and 4C). Minor molecules recognized by feline IgG had sizes of 80 kDa, 25 kDa, 28 kDa, 120 kDa, 160 kDa, 35 kDa, 20 kDa, 55 kDa, 85 kDa, and 23 kDa (Fig 4A and 4C). The major antigenic S. schenckii molecules (CBS 132974 and CBS 132984) recognized by feline IgG had sizes of: 70 kDa (100% and 100%, respectively), 90 kDa (86% and 88%, respectively), 100 kDa (76% and 82%, respectively), 38 kDa (74% and 62%, respectively), 40 kDa (64% and 56%, respectively), 52 kDa (58% and 56%, respectively), 30 kDa (50% and 34%, respectively), 55 kDa (48% and 48%, respectively), and 45 kDa (40% and 30%, respectively) (Fig 4B and 4D). The minor S. schenckii molecules recognized by feline IgG had sizes of 25 kDa, 80 kDa, 28 kDa, 110 kDa, 120 kDa, 23 kDa, 35 kDa, 160 kDa, 85 kDa, and 20 kDa (Fig 4B and 4D). Sera from uninfected cats did not react with S. brasiliensis or S. schenckii antigens. Sera from cats with other infections were also non-reactive in the immunoblot assay. The frequencies at which Sporothrix molecules were recognized in the antigen preparations are presented in S2 Table. There was no association between the number of bands recognized by each serum and the distribution and number of skin lesions on cats with sporotrichosis. We previously reported that the 60-kDa and 70-kDa proteins in S. brasiliensis and S. schenckii, respectively, are related to virulence profiles and are the main antigenic molecules during murine [3] and human [45] sporotrichosis. We also determined that this protein undergoes post-translational modification and is present as isoforms and glycoforms in the S. brasiliensis and S. schenckii proteomes [45]. We therefore investigated whether antibodies present in cat sera recognize all six isoforms in the S. brasiliensis proteome, as previously shown with human antibodies [45]. S. brasiliensis proteins were therefore resolved via 2D electrophoresis and immunoblotted with pooled sera from cats with sporotrichosis (n = 10) and optimal antibody titers according to ELISA. Serum-derived antibodies in naturally infected cats mainly recognized all six isoforms of gp60 (Fig 5). The present results confirm that S. brasiliensis 3-carboxymuconate cyclase is a highly polymorphic protein [45] with sizes of 55–62 kDa and with isoelectric points of 4. 45–4. 80. 2D immunoblotting revealed less diversity and more weakly reacting spots than 1D immunoblotting, perhaps due to protein loss during sample preparation for 2D electrophoresis (compared to the crude extracts used in 1D immunoblotting and ELISA) and serum dilution during pooling.
Gaining insight into host-parasite interplay in the immunological context is essential for understanding the emergence of feline sporotrichosis and is critical to serodiagnosis and the development of vaccines. Here, we demonstrated that antigens derived from yeast cell extracts of S. brasiliensis and S. schenckii s. str. yielded excellent results in ELISA and immunoblotting. The variety of molecules recognized by sera may be related to certain characteristics of the isolate, such as virulence, or even related to immune-system activation in each individual host. During infection, Sporothrix antigens elicit an IgG-mediated response; 3-carboxymuconate cyclase (gp60 in S. brasiliensis and gp70 in S. schenckii) is the immunodominant molecule in feline sporotrichosis, similar to murine and human disease. Therefore, this molecule may also be useful as a marker in the diagnosis of feline sporotrichosis and is a promising candidate for the development of therapeutic vaccines to tackle sporotrichosis in highly endemic areas.
Sporotrichosis is a neglected fungal disease of humans and animals that remains a serious public-health problem. Sporothrix infections persist in cats, leading to continued transmission via cat-to-cat and cat-to-human contact. Cats are the major source of transmission of Sporothrix brasiliensis to the human population. We stress the importance of implementing health policies aimed at detecting Sporothrix infection in cats as an attempt to reduce massive zoonotic transmission to humans. Early diagnosis of feline sporotrichosis is critical to recognize outbreaks areas and effectively tackle future spread of the disease among humans. We explored the diversity of molecules that are expressed by S. brasiliensis and S. schenckii and that are recognized by immunoglobulin G. Upon infection, the cat delivers an IgG-mediated response against Sporothrix antigens, similar to the response in murine and human sporotrichosis. We detected remarkable cross-reactivity among S. brasiliensis and S. schenckii antigens, supporting the hypothesis that antigenic epitopes may be conserved among closely related species. One protein, 3-carboxymuconate cyclase, was prominent in immune profiles from infected animals, using both types of Sporothrix antigens. Knowledge of the immune response in feline sporotrichosis is critical to advancing techniques for serological diagnosis, developing vaccines, and improving our understanding of Sporothrix evolution.
Proteomics-Based Characterization of the Humoral Immune Response in Sporotrichosis: Toward Discovery of Potential Diagnostic and Vaccine Antigens